NICOCCINO GET ENHANCED AND EXTENDED PATENT PROTECTION
Intellectual Property Office of Singapore is the first authority to approve the Company’s own nicotine patent which is based on the previous platform patent that Nicoccino uses through licensing. The platform patent is so far approved in eleven countries and holds a protection until 2026. The new nicotine patent provides an enhanced protection until 2033.
- ”It is very gratifying that it is Singapore that approves the patent as it is a reputable and respected body. Being able to both enhance and extend the protection of our product in Nicoccino’s own name creates additional value to the Company”, says Johan Cram, CEO for Nicoccino Holding.
The platform patent is so far approved in Sweden, US, China, Russia, Japan, Austria, New Zeeland, South Africa, Israel, South Korea and Canada. Nicoccino has submitted the application for nicotine patent in additional fifteen countries and in the EU.
For more information, visit Nicoccino‘s website www.nicoccino.se, or contact:
Johan Cram, CEO
+46 708 980 418
About Nicoccino Holding AB
Nicoccino develops and markets a patented, innovative and discrete nicotine product that instantly provides the user with nicotine without the detrimental side effects of traditional tobacco products. The product has the same name as the company – Nicoccino™ – and is manufactured through partners.
The Nicoccino Holding share is listed on Nasdaq Stockholm First North under the ticker NICO.
Remium Nordic AB is Nicocino Holding's Certified Adviser.